• LAST PRICE
    3,350.0000
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    3,350.0000 / 3,350.0000
  • Day Range
    Low 3,350.0000
    High 4,200.0000
  • 52 Week Range
    Low 2,725.0000
    High 9,979.0000
  • Volume
    2
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 3350
TimeVolumeODTC
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesODTC
Odonate Inc
49.0M
-1,232.7x
---
United StatesCYTH
Cyclo Therapeutics Inc
50.0M
-1.0x
---
United StatesBGXX
Bright Green Corp
39.0M
-3.8x
---
United StatesACST
Acasti Pharma Inc
31.5M
-0.7x
---
United StatesVYNE
Vyne Therapeutics Inc
31.5M
-0.2x
---
United StatesLEXX
Lexaria Bioscience Corp
27.0M
-2.6x
---
As of 2024-02-25

Company Information

Odonate, Inc., formerly Odonate Therapeutics, Inc., is a pharmaceutical company. The Company is focused on the development of tesetaxel, an investigational, orally administered chemotherapy agent that belongs to a class of drugs known as taxanes, which are used in the treatment of cancer. The Company is no longer in development of tesetax.

Contact Information

Headquarters
3 East 28Th Street, 10Th FloorNEW YORK, NY, United States 10016
Phone
858-200-3830
Fax
302-655-5049

Executives

Chairman of the Board, Chief Executive Officer
Kevin Tang
Chief Financial Officer
Michael Hearne
Director
Robert Rosen
Independent Director
Aaron Davis
Independent Director
Laura Douglass

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$49.0M
Revenue (TTM)
$0.00
Shares Outstanding
14.6K
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
-0.23
EPS
$-2.72
Book Value
$3.53
P/E Ratio
-1,232.7x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.